TORO BIO, INC.

Medtech · Private

Intelligent single-use bioreactor system for automated therapeutic cell expansion at the point of care

Grants
$305K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
7
0 granted · 7 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Automated System for Point of Care Manufacture of Tumor Infiltrating Lymphocytes Cell Therapies$304,870
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1640Atirix Medical Systems, Inc.—$3.0M
1641AllAccem Inc—$5.0M
1642HarmonIQ Biosciences Inc.—$30K
1643TORO BIO, INC.——
1644SPHEROFILL, LLC——
1645Microdermics Inc.—$493K
1646Carolina Molecular Inc.—$1.1M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 7
  • Tissue Processing Tools and Methodsapplication
  • Bioreactor Systemapplication
  • Tissue Processing Tools And Methods Of Using Such Toolsapplication
  • Bioreactor Systemapplication
  • Toroidal Bioreactors And Uses Thereofapplication
  • Tissue processing system and methodapplication
  • Toroidal bioreactorapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.